The gamma-glutamyl cycle is necessary for the synthesis and breakdown of glutathione (GSH), and a metabolic defect of the gamma–glutamyl cycle leads to glutathione synthetase (GS) deficiency, resulting in an increased level of 5-oxoproline in biological samples. The gene discussed is GSS; the disease is Gerstmann syndrome.